Your browser doesn't support javascript.
loading
Structure of interleukin 1 alpha at 2.7-A resolution.
Graves, B J; Hatada, M H; Hendrickson, W A; Miller, J K; Madison, V S; Satow, Y.
Afiliación
  • Graves BJ; Roche Research Center, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
Biochemistry ; 29(11): 2679-84, 1990 Mar 20.
Article en En | MEDLINE | ID: mdl-2346741
ABSTRACT
The interleukin 1 (IL-1) family of proteins has a central role in modulating immune and inflammatory responses. Two major IL-1 proteins, designated alpha (IL-1 alpha) and beta (IL-1 beta), are produced by activated macrophages and other cell types. In an effort to understand the similarities and differences in the physicochemical and functional properties of these two proteins, a program was initiated to determine their structures. Crystals of IL-1 alpha were grown, and the three-dimensional structure at 2.7-A resolution was solved. The technique of multiple-wavelength anomalous dispersion (MAD) with the selenomethionine form of IL-1 alpha was utilized in combination with a single mercury derivative to provide the starting phases. Partial refinement of the IL-1 alpha model has been performed as well. The overall structure is composed of 14 beta-strands and a 3(10) helix. The core of this structure is a capped beta-barrell that possesses 3-fold symmetry and displays a topology similar to that observed for IL-1 beta [Priestle, J. P., et al. (1988) EMBO J. 7, 339-343] and soybean trypsin inhibitor (STI) [McLachlan, A. D. (1979) J. Mol. Biol. 133, 557-563]. In this paper, the overall structure of IL-1 alpha and the nature and fidelity of the internal 3-fold symmetry are discussed. Comparisons with IL-1 beta and STI are made within these contexts.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-1 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biochemistry Año: 1990 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-1 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biochemistry Año: 1990 Tipo del documento: Article
...